Reported Feb 5, 2025 · Ongoing

Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas…

Astellas Pharma US Inc.

High riskUsing this product could cause serious injury, illness or death — stop using it now.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Astellas Pharma US Inc. · 2375 Waterview Dr · Northbrook, IL · 60062-6145

Is this the product you have?

  • Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan
  • Distributed byAstellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73
Lot codes and dates
    • Lot# 0E3353D
    • Exp 03/31/2026
Amount recalled
14,340 100-count bottles

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide

Why it was recalled

Stop using this product now

Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules

Using this product could cause serious injury, illness or death — stop using it now.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Astellas Pharma US Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 8:09 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.